These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 21045513)

  • 1. Flupenthixol-induced tardive dystonia presenting as severe dysphagia.
    Agarwal PA; Ichaporia NR
    Neurol India; 2010; 58(5):784-5. PubMed ID: 21045513
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of intractable tardive lingual dyskinesia with botulinum toxin.
    Beckmann YY; Seçil Y; Saka S; Kuserli A; Çiftçi Y
    J Clin Psychopharmacol; 2011 Apr; 31(2):250-1. PubMed ID: 21364341
    [No Abstract]   [Full Text] [Related]  

  • 3. Tardive dyskinesia: clinical presentation and treatment.
    van Harten PN; Tenback DE
    Int Rev Neurobiol; 2011; 98():187-210. PubMed ID: 21907088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of tardive lingual dystonia with botulinum toxin: case report and review of the literature.
    Hennings JM; Krause E; Bötzel K; Wetter TC
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1167-71. PubMed ID: 17936461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful botulinum toxin treatment of dysphagia in a spinal muscular atrophy type 2 patient.
    Suzukia Y; Sano N; Shinonaga C; Fukuda M; Hyodo M; Morimoto T
    Brain Dev; 2007 Nov; 29(10):662-5. PubMed ID: 17532160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin in the treatment of lingual movement disorders.
    Kasravi N; Jog MS
    Mov Disord; 2009 Nov; 24(15):2199-202. PubMed ID: 19795478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin treatment for oropharyngeal dysphagia associated with diabetic neuropathy.
    Restivo DA; Marchese-Ragona R; Lauria G; Squatrito S; Gullo D; Vigneri R
    Diabetes Care; 2006 Dec; 29(12):2650-3. PubMed ID: 17130199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin for cricopharyngeal dysphagia: case reports of CT-guided injection.
    Atkinson SI; Rees J
    J Otolaryngol; 1997 Aug; 26(4):273-6. PubMed ID: 9263899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin as a treatment for tardive dyskinesia.
    van Harten PN; Hovestadt A
    Mov Disord; 2006 Aug; 21(8):1276-7. PubMed ID: 16671083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tardive dystonia: a rare side effect after long-term neuroleptic treatment].
    Bartels M; Riffel B; Stöhr M
    Nervenarzt; 1982 Nov; 53(11):674-6. PubMed ID: 6129578
    [No Abstract]   [Full Text] [Related]  

  • 11. Severe and prolonged dysphagia complicating botulinum toxin A injections for dystonia in Machado-Joseph disease.
    Tuite PJ; Lang AE
    Neurology; 1996 Mar; 46(3):846. PubMed ID: 8618703
    [No Abstract]   [Full Text] [Related]  

  • 12. [A retrospective study of 91 injections of botulinus toxin into the upper sphincter of the oesophagus].
    Verhulst J; Amé P; Guatterie M; Barat M; Traissac L
    Rev Laryngol Otol Rhinol (Bord); 2003; 124(5):315-20. PubMed ID: 15144028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe tongue protrusion dystonia: clinical syndromes and possible treatment.
    Schneider SA; Aggarwal A; Bhatt M; Dupont E; Tisch S; Limousin P; Lee P; Quinn N; Bhatia KP
    Neurology; 2006 Sep; 67(6):940-3. PubMed ID: 17000958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tardive dystonia, a case report.
    Veras AB; Rozenthal M; Nardi AE
    Braz J Psychiatry; 2006 Jun; 28(2):160-1. PubMed ID: 16810405
    [No Abstract]   [Full Text] [Related]  

  • 15. Case studies in movement disorders.
    Evidente VG; Caviness JN; Adler CH
    Semin Neurol; 2003 Sep; 23(3):277-84. PubMed ID: 14722823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin in movement disorders.
    Papapetropoulos S; Singer C
    Semin Neurol; 2007 Apr; 27(2):183-94. PubMed ID: 17390263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The use of botulinum toxin in otorhinolaryngology--experiences and outlook].
    Laskawi R
    Laryngorhinootologie; 1997 Nov; 76(11):656-9. PubMed ID: 9517972
    [No Abstract]   [Full Text] [Related]  

  • 18. Tardive dyskinesia presenting as severe dysphagia.
    Gregory RP; Smith PT; Rudge P
    J Neurol Neurosurg Psychiatry; 1992 Dec; 55(12):1203-4. PubMed ID: 1479401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dystonia: their epidemiology, aetiology, diagnosis and treatment].
    Rodríguez-Constela I; Rodríguez-Regal A; Cebrián-Pérez EM
    Rev Neurol; 2009 Jan; 48 Suppl 1():S61-9. PubMed ID: 19222018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of schizophrenia with dysphagia successfully treated by a multidimensional approach.
    Tang KT; Hsieh MH
    Gen Hosp Psychiatry; 2010; 32(5):559.e11-3. PubMed ID: 20851279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.